USARx offers multiple ways to purchase this medication. Choose the Best option for you!
More frequently reported side effects include: edema and headache. See below for a comprehensive list of adverse effects.
Applies to isradipine: oral capsule
Along with its needed effects, isradipine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking isradipine:
Get emergency help immediately if any of the following symptoms of overdose occur while taking isradipine:
Symptoms of Overdose
Some side effects of isradipine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Applies to isradipine: oral capsule, oral tablet extended release
Isradipine is generally well-tolerated. Most side effects occurred as commonly as with placebo in placebo-controlled trials, except for flushing, headache, and palpitations.
Cardiovascular side effects are among the most common, and are related to the vasodilatory properties of isradipine. Peripheral edema and flushing are reported in 3% to 14% of patients, being more common at higher doses. Dizziness occurs in 3% to 8% of patients.
Palpitations or a greater awareness of heart beats is reported in 1% to 5% of patients. Flushing and palpitations are more likely with dosages greater than 5 mg daily; women have reported flushing more than men. Edema was reported in up to 22% of patients in one study (mean dose was 5.9 mg TID). In large studies, the incidence of edema is less than 3%, and appeared to be more likely in patients greater than 60 years of age.
Isradipine does not appear to adversely affect plasma lipids.
Headache was reported in up to 16% of patients in one study, although the mean dose was 5.9 mg three times daily to treat angina pectoris. Headache is more likely with dosages greater than 5 mg daily. Visual disturbances are reported in less than 2% of patients. Sleep disturbances are reported in 0.1% of patients.
Nervous system side effects are probably related to the vasodilatory effects of isradipine. Headache is reported in 9% to 30% of patients and fatigue is reported in 7% of patients.
Anorexia, nausea, vomiting, and diarrhea are reported in less than 4% of patients.
Gastrointestinal side effects are unusual, and include constipation in less than 2% of patients.
Respiratory system complaints include dyspnea and cough in 2% of patients.
Musculoskeletal pain is reported in 1% of patients.
Dermatologic complaints of "disturbed skin sensation" are reported in less than 4% of patients.
Hypersensitivity reactions to isradipine are rare. Pruritus, urticaria, and angioedema have been reported.
June 25, 2020
June 23, 2020
June 22, 2020
June 18, 2020
June 17, 2020
June 4, 2020